glp-1 drugs shortage As Drug Ends, Why Will Patients Pay More? GLP-1 Agonists Weight Loss Drugs

Research, analysis, and narrative by Senior Associate Sarah Grant

What are glucagon-like peptide-1 (GLP-1) receptor agonists?Glucagon-like peptide-1 receptor agonists, commonly known as GLP-1 drugs, are a class of peptide medications (not dietary supplements) primarily used to treat type 2 diabetes (T2D) and obesity

Gastrointestinal issues such as nausea, vomiting, diarrhea, and abdominal pain are among the most frequently reported side effects, especially at the start of treatment

Moreover, it remains to be shown that GIPR agonism can improve insulin secretion in type 2 diabetic patients who have been noted in previous studies to be unresponsive to GIP

Then, we will discuss the approaches that can increase the endogenous production of GLP-1 through various stimuli